Anti Cancer Capsules

Product Details:

POMALYST (Pomalidomide 1mg 2mg 4mg )is a prescription medicine used to treat adults with:
Multiple myeloma. Pomalyst is taken along with the medicine dexamethasone, in people who:have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, andtheir disease has become worse during treatment or within 60 days of finishing the last treatmentAIDS-related Kaposi sarcoma (KS). Pomalyst is taken when highly active antiretroviral therapy (HAART) has not worked well enough or stopped working (failed)KS who do not have HIV infection (HIV negative).It is not known if Pomalyst is safe and effective in children.
Who should not take Pomalyst?
Do not take Pomalyst if you:
are pregnant, plan to become pregnant, or become pregnant during treatment with Pomalyst. See “What is the most important information I should know about Pomalyst?”are allergic to pomalidomide or any of the ingredients in Pomalyst. See the end of this Medication Guide for a complete list of ingredients in Pomalyst.What are the possible side effects of Pomalyst?
Pomalyst can cause serious side effects, including:
Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) arecommon with Pomalyst, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked weekly for the first 8 weeks of treatment and monthly after that.Severe liver problems, including liver failure and death. Your healthcare provider should do blood tests to check your liver function during your treatment with Pomalyst. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems:Yellowing of your skin or the white part of your eyes (jaundice)Dark or brown (tea-colored) urinePain on the upper right side of your stomach area (abdomen)Bleeding or bruising more easily than normalFeeling very tiredSevere allergic reactions and severe skin reactions can happen with Pomalyst and may cause death.Call your healthcare provider if you develop any of the following signs or symptoms during treatment with Pomalyst:
a red, itchy, skin rashpeeling of your skin or blisterssevere itchingfeverGet emergency medical help right away if you develop any of the following signs or symptoms during treatment with Pomalyst:
swelling of your lips, mouth, tongue, or throattrouble breathing or swallowingraised red areas on your skin (hives)a very fast heartbeatyou feel dizzy or faintDizziness and confusion. See “What should I avoid while taking Pomalyst?Nerve damage. Stop taking Pomalyst and call your healthcare provider if you develop symptoms of nerve damage including: numbness, tingling, pain, burning sensation in your hands, legs, or feet.Risk of new cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received Pomalyst. Talk with your healthcare provider about your risk of developing new cancers if you take Pomalyst.Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.Your healthcare provider may tell you to stop taking Pomalyst if you develop certain serious side effects during treatment.
The most common side effects of Pomalyst in people with Multiple Myeloma include:
tiredness and weaknessconstipationnauseadiarrheashortness of breathupper respiratory tract infectionback painfever

Product Details:

Lenangio (Lenalidomide 5mg, 10mg , 25mg)is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells). Lenangio should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if Lenangio is safe and effective in children.What is the most important information I should know about Lenangio ?Before you begin takingLenangio , you must read and agree to all of the instructions in the Lenangio REMS program. Before prescribingLenangio , your healthcare provider will explain the Lenangio REMS program to you and have you sign the Patient-Physician Agreement Form.
Lenangio may cause serious side effects, including:
Possible birth defects (deformed babies) or death of an unborn baby. Females who are pregnant or who plan to become pregnant must not takeLenangio .
Lenangio is similar to the medicine thalidomide which is known to cause severe life-threatening birth defects. Lenangio has not been tested in pregnant females. Lenangio has harmed unborn animals in animal testing.Females must not get pregnant:For at least 4 weeks before startingLenangio While takingLenangio During any breaks (interruptions) in your treatment withLenangio For at least 4 weeks after stoppingLenangio Females who can become pregnant:
Must have pregnancy tests weekly for 4 weeks, then every 4 weeks if your menstrual cycle is regular, or every 2 weeks if your menstrual cycle is irregular.If you miss your period or have unusual bleeding, you will need to have a pregnancy test and receive counseling.Must agree to use 2 different forms of effective birth control at the same time, for at least 4 weeks before, while taking, during any breaks (interruptions) in your treatment, and for at least 4 weeks after stoppingLenangio .Talk with your healthcare provider to find out about options for effective forms of birth control that you may use to prevent pregnancy before, during, and after treatment withLenangio .If you had unprotected sex or if you think your birth control has failed, stop taking Lenangio immediately and call your healthcare provider right away.If you become pregnant while takingLenangio , stop taking it right away and call your healthcare provider. If your healthcare provider is not available, you can call Celgene Customer Care Center at 1-888-423-5436. Healthcare providers and patients should report all cases of pregnancy to:
FDA MedWatch at 1-800-FDA-1088, andCelgene Corporation, a Bristol Myers Squibb company, at 1-888-423-5436.There is a pregnancy exposure registry that monitors the outcomes of females who take Lenangio during pregnancy, or if their male partner takes Lenangio and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation, a Bristol Myers Squibb company, at the phone number listed above.
Lenangio can pass into human semen:
Males, including those who have had a vasectomy, must always use a latex or synthetic condom during any sexual contact with a pregnant female or a female that can become pregnant while takingLenangio , during any breaks (interruptions) in your treatment withLenangio , and for up to 4 weeks after stoppingLenangio .Do not have unprotected sexual contact with a female who is or could become pregnant. Tell your healthcare provider if you do have unprotected sexual contact with a female who is or could become pregnant.Do not donate sperm while takingLenangio , during any breaks (interruptions) in your treatment, and for 4 weeks after stoppingLenangio . If a female becomes pregnant with your sperm, the baby may be exposed to Lenangio and may be born with birth defects.

Additional Information:

• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Imbruvica (Ibrutinib 140 mg) contains the Drug/Molecule called “Ibrutinib”. Nitib is a small molecule drug that is used to bind permanently to a protein called “Bruton’s tyrosine kinase (BTK)” which is important in B cells.

Nitib 140 mg Uses –
Ibrunat is kind of a medicine which is prescribed for treating adult patients who has the following types of blood cancers:

Mantle cell lymphoma
Waldenstrom’s macroglobulinemia
Chronic Graft Versus Host Disease
Chronic lymphocytic leukemia and
Marginal zone lymphoma (MZL)
Small Lymphocytic Lymphoma
Nitib Ibrutinib is a first line treatment in the people who are newly diagnosed with CLL (Chronic lymphocytic leukemia) blood cancer & require treatment. These capsules may also be used in CLL (Chronic lymphocytic leukemia) that relapses.

How Nitib Ibrutinib 140 mg Capsule Works
Ibrutinib which is the active ingredient in Nitib 140 mg capsules, works in a manner that it blocks the activity of a specific protein called “Bruton’s tyrosine kinase”, or BTK.

Bruton’s tyrosine kinase is a protein that is found in your B cells and it sends “signals” to the other parts of the body that help B cells to survive and multiply.

But these generic ibrunat capsules block BTK & help in killing and reducing the number of cancerous B-cells. Therefore, this stops or slows the progression of cancer.

How to Take Nitib Capsule
It is prescribed to take Nitib 140 mg once in a day at about the same time every day. The dosage and duration of treatment depends on the type of blood cancer, the age of the patient, and on how severe the condition of the patient.

Moreover, it also depends on “how the patient’s body reacts to the first dose.” The Hetero Nitib Capsules should be taken orally with a glass of water. Please remember to not to open, crush, or chew the capsules.

Side Effects of Nitib Capsules –
Nitib can cause side effects like:

Bleeding,
Leukostasis,
Infections,
Decrease the blood cell counts,
Heart problems, or
Liver problems.
There are chances of occurring the new cancers in people taking Ibrunat, including skin cancer & other cancers.

The most common side effects may include:

Pneumonia,
Upper respiratory tract infection,
Diarrhea,
Feeling very tired,
nausea,
headache,
swollen hands,
ankles or feet,
being short of breath,
dizziness,
fainting,
constipation, and
infected nose.
Interactions with other drugs –

Some antiplatelet drugs like “Clopidogrel”, “NSAIDs like Ibuprofen / Naproxen”, “Blood thinners like Warfarin / Dabigatran” can cause bleeding / bruising with Nitib capsules.
The drug called aspirin can increase the risk of bleeding if it is used with Nitib Ibrutinib.
And lastly, the azole antifungals drugs such as “Itraconazole”, “Ketoconazole” can affect the removal of Nitib from body.

Product Details:

COMETRIQ (Cabozantinib 100mg) is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC). It is not known if COMETRIQ is safe and effective in children. COMETRIQ may cause serious side effects, including: A tear in your stomach or intestinal wall (perforation), or an abnormal connection between 2 parts of your body (fistula) that may lead to death. Tell your healthcare provider right away if you get tenderness or pain in your stomach area (abdomen). Bleeding (hemorrhage). COMETRIQ can cause severe bleeding that may lead to death. Tell your healthcare provider right away if you get any signs of bleeding during treatment with COMETRIQ, including: coughing up blood or blood clots vomiting blood or if your vomit looks like coffee grounds red or black (looks like tar) stools menstrual bleeding that is heavier than normal any unusual or heavy bleeding Blood clots, stroke, heart attack, and chest pain. Get emergency help right away if you get: swelling or pain in your arms or legs shortness of breath light-headed or faint sweating more than usual numbness or weakness of your face, arm, or leg, especially on one side of your body sudden confusion, trouble speaking or understanding sudden trouble seeing in one or both eyes sudden trouble walking dizziness, loss of balance or coordination a sudden severe headache Wound healing problems. Wound healing problems have happened in some people who take COMETRIQ. Tell your healthcare provider if you plan to have any surgery before or during treatment with COMETRIQ. You should stop taking COMETRIQ at least 3 weeks before planned surgery. Your healthcare provider should tell you when you may start taking COMETRIQ again after surgery. High blood pressure (hypertension). Hypertension is common with COMETRIQ and can be severe. Your healthcare provider will check your blood pressure before you start and during treatment with COMETRIQ. If needed, your healthcare provider may prescribe medicine to treat your high blood pressure. Severe jaw bone problems (osteonecrosis). Symptoms may include jaw pain, toothache, or sores on your gums. Your healthcare provider should examine your mouth before you start and during treatment with COMETRIQ. Tell your dentist that you are taking COMETRIQ. It is important for you to practice good mouth care during treatment with COMETRIQ. Diarrhea. Diarrhea is common with COMETRIQ and can be severe. If needed, your healthcare provider may prescribe medicine to treat your diarrhea. Tell your healthcare provider right away if you have frequent loose, watery bowel movements. A skin problem called hand-foot skin reaction. Hand-foot skin reactions are common with COMETRIQ and can be severe. Tell your healthcare provider right away if you have rashes, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet. Protein in your urine and possible kidney problems. Symptoms may include swelling in your hands, arms, legs, or feet. Reversible posterior leukoencephalopathy syndrome (RPLS). A condition called reversible posterior leukoencephalopathy syndrome can happen during treatment with COMETRIQ. Tell your healthcare provider right away if you have headaches, seizures, confusion, changes in vision, or problems thinking. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with COMETRIQ if you have certain side effects.

Product Details:

Cabozantinib 100mg is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC).It is not known if Cabozantinib  is safe and effective in children.Cabozantinib  may cause serious side effects, including:A tear in your stomach or intestinal wall (perforation), or an abnormal connection between 2 parts of your body (fistula) that may lead to death. Tell your healthcare provider right away if you get tenderness or pain in your stomach area (abdomen).Bleeding (hemorrhage). Cabozantinib  can cause severe bleeding that may lead to death. Tell your healthcare provider right away if you get any signs of bleeding during treatment with Cabozantinib , including:coughing up blood or blood clotsvomiting blood or if your vomit looks like coffee groundsred or black (looks like tar) stoolsmenstrual bleeding that is heavier than normalany unusual or heavy bleedingBlood clots, stroke, heart attack, and chest pain. Get emergency help right away if you get:swelling or pain in your arms or legsshortness of breathlight-headed or faintsweating more than usualnumbness or weakness of your face, arm, or leg, especially on one side of your bodysudden confusion, trouble speaking or understandingsudden trouble seeing in one or both eyessudden trouble walkingdizziness, loss of balance or coordinationa sudden severe headacheWound healing problems. Wound healing problems have happened in some people who take Cabozantinib . Tell your healthcare provider if you plan to have any surgery before or during treatment with Cabozantinib .You should stop taking Cabozantinib  at least 3 weeks before planned surgery.Your healthcare provider should tell you when you may start taking Cabozantinib  again after surgery.High blood pressure (hypertension). Hypertension is common with Cabozantinib  and can be severe. Your healthcare provider will check your blood pressure before you start and during treatment with Cabozantinib . If needed, your healthcare provider may prescribe medicine to treat your high blood pressure.Severe jaw bone problems (osteonecrosis). Symptoms may include jaw pain, toothache, or sores on your gums. Your healthcare provider should examine your mouth before you start and during treatment with Cabozantinib . Tell your dentist that you are taking Cabozantinib . It is important for you to practice good mouth care during treatment with Cabozantinib .Diarrhea. Diarrhea is common with Cabozantinib  and can be severe. If needed, your healthcare provider may prescribe medicine to treat your diarrhea. Tell your healthcare provider right away if you have frequent loose, watery bowel movements.A skin problem called hand-foot skin reaction. Hand-foot skin reactions are common with Cabozantinib  and can be severe. Tell your healthcare provider right away if you have rashes, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet.Protein in your urine and possible kidney problems. Symptoms may include swelling in your hands, arms, legs, or feet.Reversible posterior leukoencephalopathy syndrome (RPLS). A condition called reversible posterior leukoencephalopathy syndrome can happen during treatment with Cabozantinib . Tell your healthcare provider right away if you have headaches, seizures, confusion, changes in vision, or problems thinking.Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with Cabozantinib  if you have certain side effects.

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Pomahope (Pomalidomide 1mg, 2mg, 4mg )is a prescription medicine used to treat adults with:
Multiple myeloma. Pomahope is taken along with the medicine dexamethasone, in people who:have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, andtheir disease has become worse during treatment or within 60 days of finishing the last treatmentAIDS-related Kaposi sarcoma (KS). Pomahope is taken when highly active antiretroviral therapy (HAART) has not worked well enough or stopped working (failed)KS who do not have HIV infection (HIV negative).It is not known if Pomahope is safe and effective in children.
Who should not take Pomahope?
Do not take Pomahope if you:
are pregnant, plan to become pregnant, or become pregnant during treatment with Pomahope. See “What is the most important information I should know about Pomahope?”are allergic to pomalidomide or any of the ingredients in Pomahope. See the end of this Medication Guide for a complete list of ingredients in Pomahope.What are the possible side effects of Pomahope?
Pomahope can cause serious side effects, including:
Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) arecommon with Pomahope, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked weekly for the first 8 weeks of treatment and monthly after that.Severe liver problems, including liver failure and death. Your healthcare provider should do blood tests to check your liver function during your treatment with Pomahope. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems:Yellowing of your skin or the white part of your eyes (jaundice)Dark or brown (tea-colored) urinePain on the upper right side of your stomach area (abdomen)Bleeding or bruising more easily than normalFeeling very tiredSevere allergic reactions and severe skin reactions can happen with Pomahope and may cause death.Call your healthcare provider if you develop any of the following signs or symptoms during treatment with Pomahope:
a red, itchy, skin rashpeeling of your skin or blisterssevere itchingfeverGet emergency medical help right away if you develop any of the following signs or symptoms during treatment with Pomahope:
swelling of your lips, mouth, tongue, or throattrouble breathing or swallowingraised red areas on your skin (hives)a very fast heartbeatyou feel dizzy or faintDizziness and confusion. See “What should I avoid while taking Pomahope?Nerve damage. Stop taking Pomahope and call your healthcare provider if you develop symptoms of nerve damage including: numbness, tingling, pain, burning sensation in your hands, legs, or feet.Risk of new cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received Pomahope. Talk with your healthcare provider about your risk of developing new cancers if you take Pomahope.Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.Your healthcare provider may tell you to stop taking Pomahope if you develop certain serious side effects during treatment.
The most common side effects of Pomahope in people with Multiple Myeloma include:
tiredness and weaknessconstipationnauseadiarrheashortness of breathupper respiratory tract infectionback painfever.

Product Details:

Pomalid (Pomalidomide 1mg,2mg,4mg) is a prescription medicine used to treat adults with: Multiple myeloma. Pomalid is taken along with the medicine dexamethasone, in people who:have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, andtheir disease has become worse during treatment or within 60 days of finishing the last treatmentAIDS-related Kaposi sarcoma (KS). Pomalid is taken when highly active antiretroviral therapy (HAART) has not worked well enough or stopped working (failed)KS who do not have HIV infection (HIV negative).It is not known if Pomalid is safe and effective in children.
Who should not take Pomalid?
Do not take Pomalid if you:
are pregnant, plan to become pregnant, or become pregnant during treatment with Pomalid. See “What is the most important information I should know about Pomalid?”are allergic to pomalidomide or any of the ingredients in Pomalid. See the end of this Medication Guide for a complete list of ingredients in Pomalid.What are the possible side effects of Pomalid?
Pomalid can cause serious side effects, including: Low white blood cells (neutropenia), low platelets (thrombocytopenia), and low red blood cells (anemia) arecommon with Pomalid, but can also be serious. You may need a blood transfusion or certain medicines if your blood counts drop too low. Your blood counts should be checked weekly for the first 8 weeks of treatment and monthly after that.Severe liver problems, including liver failure and death. Your healthcare provider should do blood tests to check your liver function during your treatment with Pomalid. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems:Yellowing of your skin or the white part of your eyes (jaundice)Dark or brown (tea-colored) urinePain on the upper right side of your stomach area (abdomen)Bleeding or bruising more easily than normalFeeling very tiredSevere allergic reactions and severe skin reactions can happen with Pomalid and may cause death.Call your healthcare provider if you develop any of the following signs or symptoms during treatment with Pomalid:
a red, itchy, skin rashpeeling of your skin or blisterssevere itchingfeverGet emergency medical help right away if you develop any of the following signs or symptoms during treatment with Pomalid:
swelling of your lips, mouth, tongue, or throattrouble breathing or swallowingraised red areas on your skin (hives)a very fast heartbeatyou feel dizzy or faintDizziness and confusion. See “What should I avoid while taking Pomalid?Nerve damage. Stop taking Pomalid and call your healthcare provider if you develop symptoms of nerve damage including: numbness, tingling, pain, burning sensation in your hands, legs, or feet.Risk of new cancers (malignancies). New cancers, including certain blood cancers (acute myelogenous leukemia or AML) have been seen in people who received Pomalid. Talk with your healthcare provider about your risk of developing new cancers if you take Pomalid.Tumor lysis syndrome (TLS). TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.Your healthcare provider may tell you to stop taking Pomalid if you develop certain serious side effects during treatment.
The most common side effects of Pomalid in people with Multiple Myeloma include:
tiredness and weakness constipation nauseadi arrheashortness of breathupper respiratory tract infectionback painfever

The most common side effects of Pomalid in people with KS include: Tirednessdiarrheaabnormal kidney function testsdecreased phosphate and calcium in the bloodrash. See “Severe allergic reactions and severe skin reactions” above.

Product Details:

Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is taken by mouth in the form of capsules.

Common side effects include diarrhea, constipation and low platelet count. Like the older bortezomib (which can only be given by injection), it acts as a proteasome inhibitor, has orphan drug status in the US and Europe, and is a boronic acid derivative.

Ixazomib is used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adults after at least one prior therapy. There are no experiences with children and youths under 18 years of age.
Common side effects of the ixazomib+lenalidomide+dexamethasone study therapy included diarrhoea (42% versus 36% under placebo+lenalidomide+dexamethasone), constipation (34% versus 25%), thrombocytopenia (low platelet count; 28% versus 14%), peripheral neuropathy (28% versus 21%), nausea (26% versus 21%), peripheral oedema (swelling; 25% versus 18%), vomiting (22% versus 11%), and back pain (21% versus 16%). Serious diarrhoea or thrombocytopenia occurred in 2% of patients, respectively.

Product Details:

SYPRINE (Trientine Hydrochloride 250mg) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. SYPRINE is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis. IMPORTANT SAFETY INFORMATION Do not take SYPRINE if you are allergic to it or any parts of the formulation. You should remain under regular medical supervision the entire time you are taking SYPRINE. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women. Take SYPRINE® on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor. Tell your doctor if you are pregnant, plan to become pregnant, or are nursing. The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis. Do not take mineral supplements because they may block the absorption of SYPRINE.

Disclaimer:

• Trademark shown are property of their respective owners and we do not lay any claim on them.  Parall